Salivary Secretory Carcinoma in a Patient with Immature Ovary Teratoma

Document Type : Case Report

Authors

1 Department of Oral and Maxillofacial Pathology, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2 Research Committee, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

3 Graduated Student, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Introduction:
Secretory carcinoma, previously known as mammary analog secretory carcinoma, is a rare malignancy of salivary glands. It has a diversity of microscopic patterns and is similar to other salivary gland tumors.
 Case Report:
This report presents the case of a 32-year-old female patient with a painless swelling of the upper lip and a history of recent surgery for an immature ovarian teratoma.  The microscopic sections revealed a circumscribed neoplasm composed of macrocystic, papillary-cystic, and microcystic patterns with bland vesicular nuclei and vacuolated cytoplasm. Tumoral cells were strongly positive for mammaglobin, SOX10, GATA3, S-100, and vimentin. The diagnosis of salivary gland secretory carcinoma was made. After 22 months, there has been no recurrence.
 Conclusions:
As secretory carcinoma is a relatively new entity, it is necessary to understand its characteristics. Although the overall incidence of second primary cancer in patients with salivary gland cancers is low, the possibility of its presence in such patients should be considered.

Keywords

Main Subjects

References

  1. Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5):599-608.
  2. Alves LDB, de Melo AC, Farinha TA, de Lima Araujo LH, Thiago LS, Dias FL, et al. A systematic review of secretory carcinoma of the salivary gland: where are we? Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;132(4):e143-e52.
  3. Ogawa M, Yokoo S, Yamaguchi T, Suzuki K, Seki-Soda M, Shimizu T, et al. Diagnosis and treatment of secretory carcinoma arising from the oral minor salivary gland: Two case reports. Medicine (Baltimore). 2021;100(51):e28390.
  4. Taverna C, Baněčková M, Lorenzon M, Palomba A, Franchi A, Skalova A, et al. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics. Histopathology. 2021;79(3):315-24.
  5. Kwon M, Lee JI, Roh JL, Cho KJ, Choe J, Choi SH, et al. Second cancer incidence and risk factors in patients with salivary gland cancers. JAMA Otolaryngol Head Neck Surg. 2014;140(2):118-23.
  6. Biggar RJ, Curtis RE, Hoffman DA, Flannery JT. Second primary malignancies following salivary gland cancers. Br J Cancer. 1983;47(3):383-6.
  7. Prior P, Waterhouse JA. Second primary cancers in patients with tumours of the salivary glands. Br J Cancer. 1977;36(3):362-8.
  8. Venkat S, Fitzpatrick S, Drew PA, Bhattacharyya I, Cohen DM, Islam MN. Secretory Carcinoma of the Oral Cavity: A Retrospective Case Series with Review of Literature. Head Neck Pathol. 2021;15(3):893-904.
  9. Owosho AA, Tyler D, Summersgill KF. A clinicopathologic study of secretory carcinoma of minor salivary gland: a series of 4 cases and diagnostic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131(4):463-7.
  10. Wiles AB, Gabrielson M, Baloch ZW, Faquin WC, Jo VY, Callegari F, et al. Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study. Cancer Cytopathol. 2022;130(9):684-94.
  11. Gorbokon N, Timm P, Dum D, Menz A, Büscheck F, Völkel C, et al. Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland. Diagnostics (Basel). 2023;13(6).
  12. Xu B, Viswanathan K, Umrau K, Al-Ameri TAD, Dogan S, Magliocca K, et al. Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors. Histopathology. 2022;81(5):670-9.
  13. Yang J, Wei R, Song X, Sun X, Wang H, Liu Q, et al. Risk of second primary malignancy after minor salivary gland cancer: A Surveillance, Epidemiology, and End Results database analysis. Head Neck. 2021;43(6):1769-79.
  14. Wang H, Zhang Y, Wang B, Wei J, Ji R, Dong L, et al. Epithelial-myoepithelial carcinoma of the parotid gland with primary lung cancer: A rare case report. Medicine (Baltimore). 2020;99(40):e22483.
  15. Zaccarini DJ, Khurana KK. Incidence of Non-Salivary Gland Neoplasms in Patients with Warthin Tumor: A Study of 73 Cases. Head Neck Pathol. 2020;14(2):412-8.

 

 

 

 

Iranian Journal of Otorhinolaryngology
Volume 36, Issue 4
July and August 2024
Pages 567-571

Files

Share

How to cite

Statistics